WVE - CIK 0001631574
Wave Life Sciences Ltd. (WVE) reported net income of -$204.38M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$204.38M | -110.7% |
| FY 2024 | -$97.01M | -68.7% |
| FY 2023 | -$57.51M | +64.5% |
| FY 2022 | -$161.82M | -32.4% |
| FY 2021 | -$122.25M | +18.5% |
| FY 2020 | -$149.91M | +22.6% |
| FY 2019 | -$193.64M | -32.0% |
| FY 2018 | -$146.65M | -43.8% |
| FY 2017 |
Wave Life Sciences Ltd. (WVE) reported net income of -$204.38M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2013 and fiscal 2025, Wave Life Sciences Ltd.'s net income declined from -$3.32M to -$204.38M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$101.98M |
| -83.2% |
| FY 2016 | -$55.66M | -189.9% |
| FY 2015 | -$19.20M | -267.2% |
| FY 2014 | -$5.23M | -57.6% |
| FY 2013 | -$3.32M | - |